Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
TSX:VPH
Price:
0.115 CAD
4.55%
Updated:
May 3, 2024
Valeo Pharma Inc
Cash from Operating Activities
|
Valeo Pharma Inc
Cash from Operating Activities Peer Comparison
Comparables:
BHC
TH
K
GUD
EDT
CPH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Valeo Pharma Inc
TSX:VPH
|
Cash from Operating Activities
-CA$15.7m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Operating Activities
$1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
Theratechnologies Inc
TSX:TH
|
Cash from Operating Activities
-$4m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash from Operating Activities
CA$35.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Operating Activities
-CA$10.7m
|
CAGR 3-Years
-222%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-2%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Cash from Operating Activities
$16m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
See Also
What is Valeo Pharma Inc's Cash from Operating Activities?
Cash from Operating Activities
-15.7m
CAD
-15.7m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Cash from Operating Activities amounts to -15.7m CAD.
What is Valeo Pharma Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-64%
-64%
Over the last year, the Cash from Operating Activities growth was 45%. The average annual Cash from Operating Activities growth rates for Valeo Pharma Inc have been -44% over the past three years , -64% over the past five years .
You don't have any saved screeners yet
